phase readout
saveNCT03126916: Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Children's Oncology Group. Phase: PHASE3. Conditions: Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma
view source ↗
comments(0)
5-min edit window · permanent after that